持田製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2017/06/02 | 8,020 | 8,030 | 7,960 | 8,000 | +20 | +0.3% | 60,300 |
2017/06/01 | 7,880 | 7,990 | 7,880 | 7,980 | +150 | +1.9% | 45,700 |
2017/05/31 | 7,910 | 7,950 | 7,830 | 7,830 | -90 | -1.1% | 46,400 |
2017/05/30 | 7,960 | 7,980 | 7,900 | 7,920 | -50 | -0.6% | 22,800 |
2017/05/29 | 8,060 | 8,100 | 7,960 | 7,970 | -70 | -0.9% | 48,900 |
2017/05/26 | 8,160 | 8,170 | 8,010 | 8,040 | -160 | -2% | 60,800 |
2017/05/25 | 8,280 | 8,320 | 8,180 | 8,200 | -150 | -1.8% | 53,300 |
2017/05/24 | 8,480 | 8,540 | 8,310 | 8,350 | -130 | -1.5% | 48,100 |
2017/05/23 | 8,560 | 8,610 | 8,450 | 8,480 | -110 | -1.3% | 49,800 |
2017/05/22 | 8,640 | 8,640 | 8,550 | 8,590 | -120 | -1.4% | 45,000 |
2017/05/19 | 8,800 | 8,800 | 8,660 | 8,710 | -70 | -0.8% | 32,900 |
2017/05/18 | 8,780 | 8,840 | 8,740 | 8,780 | -70 | -0.8% | 46,100 |
2017/05/17 | 8,890 | 8,960 | 8,840 | 8,850 | -80 | -0.9% | 49,300 |
2017/05/16 | 8,910 | 8,980 | 8,820 | 8,930 | -40 | -0.4% | 76,500 |
2017/05/15 | 8,720 | 9,040 | 8,720 | 8,970 | +140 | +1.6% | 53,700 |
2017/05/12 | 8,750 | 8,850 | 8,740 | 8,830 | ±0 | ±0% | 26,900 |
2017/05/11 | 8,760 | 8,880 | 8,760 | 8,830 | -50 | -0.6% | 38,100 |
2017/05/10 | 8,780 | 8,890 | 8,760 | 8,880 | +70 | +0.8% | 30,800 |
2017/05/09 | 8,730 | 8,820 | 8,680 | 8,810 | +20 | +0.2% | 30,700 |
2017/05/08 | 8,590 | 8,840 | 8,520 | 8,790 | +360 | +4.3% | 72,300 |
2017/05/02 | 8,380 | 8,470 | 8,370 | 8,430 | -40 | -0.5% | 41,400 |
2017/05/01 | 8,410 | 8,490 | 8,390 | 8,470 | +70 | +0.8% | 22,600 |
2017/04/28 | 8,380 | 8,430 | 8,320 | 8,400 | +80 | +1% | 33,900 |
2017/04/27 | 8,310 | 8,370 | 8,250 | 8,320 | +30 | +0.4% | 49,500 |
2017/04/26 | 8,380 | 8,380 | 8,240 | 8,290 | -20 | -0.2% | 29,500 |
2017/04/25 | 8,370 | 8,430 | 8,260 | 8,310 | -50 | -0.6% | 34,400 |
2017/04/24 | 8,350 | 8,390 | 8,300 | 8,360 | +120 | +1.5% | 21,400 |
2017/04/21 | 8,160 | 8,240 | 8,120 | 8,240 | +80 | +1% | 26,700 |
2017/04/20 | 8,140 | 8,210 | 8,040 | 8,160 | +50 | +0.6% | 30,200 |
2017/04/19 | 8,110 | 8,210 | 8,100 | 8,110 | -20 | -0.2% | 30,600 |
2017/04/18 | 8,280 | 8,280 | 8,110 | 8,130 | -30 | -0.4% | 16,700 |
2017/04/17 | 8,030 | 8,180 | 8,030 | 8,160 | +130 | +1.6% | 16,800 |
2017/04/14 | 8,160 | 8,180 | 8,010 | 8,030 | -140 | -1.7% | 20,900 |
2017/04/13 | 8,150 | 8,200 | 8,120 | 8,170 | -60 | -0.7% | 24,900 |
2017/04/12 | 8,150 | 8,230 | 8,090 | 8,230 | -10 | -0.1% | 31,900 |
2017/04/11 | 8,110 | 8,260 | 8,070 | 8,240 | +110 | +1.4% | 27,300 |
2017/04/10 | 8,250 | 8,300 | 8,120 | 8,130 | -110 | -1.3% | 32,300 |
2017/04/07 | 8,170 | 8,350 | 8,170 | 8,240 | +20 | +0.2% | 38,000 |
2017/04/06 | 8,400 | 8,410 | 8,180 | 8,220 | -150 | -1.8% | 19,900 |
2017/04/05 | 8,340 | 8,470 | 8,300 | 8,370 | -20 | -0.2% | 30,800 |
2017/04/04 | 8,360 | 8,410 | 8,300 | 8,390 | +20 | +0.2% | 29,000 |
2017/04/03 | 8,350 | 8,410 | 8,300 | 8,370 | +110 | +1.3% | 24,100 |
2017/03/31 | 8,530 | 8,540 | 8,260 | 8,260 | -160 | -1.9% | 42,200 |
2017/03/30 | 8,580 | 8,600 | 8,410 | 8,420 | -250 | -2.9% | 22,300 |
2017/03/29 | 8,690 | 8,750 | 8,650 | 8,670 | -100 | -1.1% | 21,000 |
2017/03/28 | 8,680 | 8,790 | 8,660 | 8,770 | +210 | +2.5% | 31,900 |
2017/03/27 | 8,660 | 8,680 | 8,540 | 8,560 | -80 | -0.9% | 30,200 |
2017/03/24 | 8,510 | 8,660 | 8,480 | 8,640 | +110 | +1.3% | 24,900 |
2017/03/23 | 8,500 | 8,590 | 8,500 | 8,530 | -80 | -0.9% | 17,500 |
2017/03/22 | 8,600 | 8,670 | 8,600 | 8,610 | -130 | -1.5% | 19,600 |
1951~
2000
件表示中 / 3709件
類似銘柄と比較する
現在ご覧いただいている「持田薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
持田薬 | 299,100円 | +5.1% | -7.0% | 2.67% | 19.63倍 | 0.82倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
東和薬品 | 306,000円 | +7.9% | -3.3% | 2.61% | 8.51倍 | 0.88倍 |
|
後発医薬品メーカーで国内2強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
ゼリア新薬 | 217,700円 | +3.1% | -6.5% | 2.20% | 10.10倍 | 1.07倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
杏林製薬 | 149,300円 | -2.4% | -52.3% | 3.82% | 17.87倍 | 0.63倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
ネクセラファーマ | 91,700円 | +20.3% | - | 0.00% | 162.59倍 | 1.21倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
市場注目の銘柄
チャート関連のコラム